Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt.Likely | 15 | - |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 15 | - |
| 3 | Schedule 3 | KANAK ENTERPRISESLikely | 1 | ₹1,020 |
| 4 | Schedule 4 | Not yet disclosed by govt.Likely | 15 | - |
| 5 | Schedule 5 | SHREE DADU MEDICAL AGENCYLikely | 6 | ₹1,230 |
Tender Value
₹94,050
EMD Value
Exempted
Closing Date
29 Sept 2025, 6:00 pmClosed
FEXOFENADINE 120MG TAB
Fenofibrate 135 mg Cap
FRUSEMIDE 40 MG LASIX TAB
GLIPIZIDE 5 MG TAB
Gloves size 7.5 pair of powder free Ansell
8376295
GEM/2025/B/6705738
Two Packet Bid
GLIPIZIDE 5 MG TAB
20 days
Rajasthan; Ajmer
Item wise evaluation
BOQ
5 documents required · 5 mandatory
1 yrs
₹31
₹2 L
10%
Exempted
29 Sept 2025
19 Sept 2025
29 Sept 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | FEXOFENADINE 120MG TAB | As per pdf | 12,000 | NO | AJMER | 20 |
| 2 | Fenofibrate 135 mg Cap | As per pdf | 6,000 | NO | AJMER | 20 |
| 3 | FRUSEMIDE 40 MG LASIX TAB | As per pdf | 3,000 | NO | AJMER | 20 |
| 4 | GLIPIZIDE 5 MG TAB | As per pdf | 2,000 | NO | AJMER | 20 |
| 5 | Gloves size 7.5 pair of powder free Ansell | As per pdf | 100 | PAIR | AJMER | 20 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8376295.pdf
GEM_BID
pdf_18_2025-09-19-16-58-37_0c2249e5006d9f8bf25257f00ab3c35e.pdf
BOQ
sheet_18_2025-09-19-16-58-37_0ccca07f2eb555baed150453f307145a.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .